Pathology Analysis & Statistics, May 2013 (p50)

Talk to Amrita

+1 718 303 2019

Publishers

All regions

You might be interested in: cancer, breast cancer, prostate cancer, more »

1471-1520 of about 6 000 reports

Purchase Reports From Reputable Market Research Publishers

Photocure ASA (Symbol:PHO) SWOT Analysis, Strategy, Revenues and Profits

Photocure ASA (Symbol:PHO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • May 2014
  • by Global Data

Photocure ASA (Photocure) is engaged in the development and marketing of pharmaceuticals and medical devices for the diagnosis and treatment of various types of cancer and precancerous conditions based ...

  • Industries : Pathology
  • Countries : United States
NeuroSearch AS (Symbol:NEUR) SWOT Analysis, Strategy, Revenues and Profits

NeuroSearch AS (Symbol:NEUR) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • May 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
Progenics Pharmaceuticals, Inc. (Symbol:PGNX) SWOT Analysis, Strategy, Revenues and Profits

Progenics Pharmaceuticals, Inc. (Symbol:PGNX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • May 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
Ocular Pain - Pipeline Review, H1 2014

Ocular Pain - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • May 2014
  • by Global Markets Direct

Ocular Pain - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Ocular Pain - Pipeline Review, H1 2014', provides an overview of the Ocular Pain's therapeutic pipeline. This report provides ...

  • Industries : Pathology
  • Countries : World
Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H1 2014

Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • May 2014
  • by Global Markets Direct

Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H1 2014', provides an overview of the Acquired ...

  • Industries : Pathology
  • Countries : World
Blepharitis - Pipeline Review, H1 2014

Blepharitis - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • May 2014
  • by Global Markets Direct

Blepharitis - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Blepharitis - Pipeline Review, H1 2014', provides an overview of the Blepharitis's therapeutic pipeline. This report provides ...

  • Industries : Pathology
  • Countries : World
Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2014

Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • May 2014
  • by Global Markets Direct

Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Elephantiasis (Lymphatic Filariasis) - Pipeline Review, H1 2014', provides an overview of the Elephantiasis ...

  • Industries : Pathology
  • Countries : World
Pancreatic Cancer - Pipeline Review, H1 2014

Pancreatic Cancer - Pipeline Review, H1 2014

  • $ 2 500
  • Industry report
  • May 2014
  • by Global Markets Direct

Pancreatic Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Pancreatic Cancer - Pipeline Review, H1 2014', provides an overview of the Pancreatic Cancer's therapeutic pipeline. This ...

  • Industries : Pathology
Community Acquired Pneumonia - Pipeline Review, H1 2014

Community Acquired Pneumonia - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • May 2014
  • by Global Markets Direct

Community Acquired Pneumonia - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Community Acquired Pneumonia - Pipeline Review, H1 2014', provides an overview of the Community Acquired Pneumonia's ...

  • Industries : Pathology
  • Countries : World
Cataract - Pipeline Review, H1 2014

Cataract - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • May 2014
  • by Global Markets Direct

Cataract - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Cataract - Pipeline Review, H1 2014', provides an overview of the Cataract's therapeutic pipeline. This report provides comprehensive ...

  • Industries : Pathology
  • Countries : World
Toxoplasmosis - Pipeline Review, H1 2014

Toxoplasmosis - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • May 2014
  • by Global Markets Direct

Toxoplasmosis - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Toxoplasmosis - Pipeline Review, H1 2014', provides an overview of the Toxoplasmosis's therapeutic pipeline. This report provides ...

  • Industries : Pathology
  • Countries : World
Hand, Foot And Mouth Disease - Pipeline Review, H1 2014

Hand, Foot And Mouth Disease - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • May 2014
  • by Global Markets Direct

Hand, Foot And Mouth Disease - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Hand, Foot And Mouth Disease - Pipeline Review, H1 2014', provides an overview of the Hand, Foot And Mouth Disease's ...

  • Industries : Pathology
  • Countries : World
Boston Scientific Corporation (Symbol:BSX) SWOT Analysis, Strategy, Revenues and Profits

Boston Scientific Corporation (Symbol:BSX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • May 2014
  • by Global Data

Boston Scientific Corporation (Boston Scientific) is a global medical device company engaged in developing, manufacturing and marketing of medical devices that are used in a range of interventional medical ...

  • Industries : Pathology
Lpath, Inc. (Symbol:LPTN) SWOT Analysis, Strategy, Revenues and Profits

Lpath, Inc. (Symbol:LPTN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • May 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2014

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • May 2014
  • by Global Markets Direct

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2014', provides ...

  • Industries : Pathology
  • Countries : World
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) - Pipeline Review, H1 2014

Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • May 2014
  • by Global Markets Direct

Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) - Pipeline Review, H1 2014', provides ...

  • Industries : Pathology
  • Countries : World, South Korea
Uveal Melanoma - Pipeline Review, H1 2014

Uveal Melanoma - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • May 2014
  • by Global Markets Direct

Uveal Melanoma - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Uveal Melanoma - Pipeline Review, H1 2014', provides an overview of the Uveal Melanoma's therapeutic pipeline. This report ...

  • Industries : Pathology
  • Countries : World
Sophiris Bio, Inc. (SHS) - Financial and Strategic SWOT Analysis Review

Sophiris Bio, Inc. (SHS) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • May 2014
  • by Global Data

Sophiris Bio, Inc. (SHS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData ...

  • Industries : Pathology
Genoptix, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Genoptix, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Genoptix, Inc. (Genoptix) is a specialized laboratory service provider. The company delivers comprehensive diagnostic services to community-based hematologists and oncologists. It provides a differentiated, ...

  • Industries : Pathology
  • Countries : United States
Geron Corporation (GERN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Geron Corporation (GERN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Geron Corporation (Geron) is a biopharmaceutical company. It develops first-in-class therapies for cancer, including its telomerase inhibitor, imetelstat by utilizing its proprietary nucleic acid ...

  • Industries : Pathology
  • Countries : United States
Telik, Inc. (TELK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Telik, Inc. (TELK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Telik, Inc. (Telik) is a development stage bio pharmaceutical company. It carries out discovery, development and commercialization of novel small molecule drugs for the treatment of cancer and ...

  • Industries : Pathology
  • Countries : United States
H. Lundbeck AS (LUN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

H. Lundbeck AS (LUN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary H. Lundbeck A/S (Lundbeck) is a pharmaceutical company, involved in the research, development, manufacturing and marketing of pharmaceuticals for the treatment of diseases related to the central ...

  • Industries : Pathology
  • Countries : United States, Denmark, United Kingdom, Ireland
GTx, Inc. (GTXI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GTx, Inc. (GTXI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary GTx, Inc. (GTx) is a biopharmaceutical company. It identifies, develops and commercializes small molecules that target the hormone pathways for the treatment of cancer, osteoporosis and bone loss, ...

  • Industries : Pathology
  • Countries : United States
Roswell Park Cancer Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Roswell Park Cancer Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Roswell Park Cancer Institute (RPCI) is a cancer treatment center. The institute offers a wide range of educational and research services. It also offers healthcare services. The institute's R&D ...

  • Industries : Pathology
Advanced Biological Laboratories S.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Advanced Biological Laboratories S.A. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Advanced Biological Laboratories S.A. (ABL) is a healthcare IT company. The company provides integrated software solutions for personalized medicine. Its products include TherapyEdge, ViroScore, ...

  • Industries : Pathology
Ambit Biosciences Corporation (AMBI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Ambit Biosciences Corporation (AMBI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Ambit Biosciences (Ambit) is a biopharmaceutical company. The company discovers, develops and commences small molecule therapeutics for the treatment of cancer. Its products include quizartinib, ...

  • Industries : Pathology
  • Countries : United States
Tauriga Sciences Inc. (TAUG) - Power - Deals and Alliances Profile

Tauriga Sciences Inc. (TAUG) - Power - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Tauriga Sciences Inc. (Tauriga), formerly known as Immunovative, Inc., is a pharmaceutical company. It undertakes the development and commercialization of novel biological drug products and treatment ...

  • Industries : Pathology
  • Countries : Canada
Retrophin, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Retrophin, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Retrophin, LLC (Retrophin) is a biotechnology company. Retrophin discovers and develops treatments for rare and life threatening diseases. Currently, the company is developing treatments for focal ...

  • Industries : Pathology
  • Countries : United States
GenVec, Inc. (GNVC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GenVec, Inc. (GNVC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary GenVec, Inc. (GenVec) is a biopharmaceutical company. It uses differentiated and proprietary technologies to produce therapeutics and vaccines. The company's development programs address therapeutic ...

  • Industries : Pathology
  • Countries : United States
Activaero GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Activaero GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Activaero GmbH (Activaero) is a product development company. The company focuses on the development of products for the treatment of respiratory diseases. It specializes in the development of therapies ...

  • Industries : Pathology
About 38 000 reports

Download Unlimited Documents from Trusted Public Sources

Global Pathology Description - Forecast

  • Draft Proposed Programme Budget 2016-2017
  • September 2014
    102 pages
  • Infectious Dise...  

  • World  

View report >

About 200 Companies

Read our Company Profiles

Novartis Inc.

Switzerland

Johnson and Johnson

United States

GlaxoSmithKline P.L.C.

United States

Covidien PLC

Ireland

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.